HIV clades | n | % |
---|
C | 5 | 9.8 |
D | 7 | 13.7 |
A | 4 | 7.8 |
CÂ +Â D | 12 | 23.5 |
CÂ +Â A | 1 | 2.0 |
DÂ +Â A | 7 | 13.7 |
CÂ +Â DÂ +Â A | 15 | 29.4 |
Total | 51 | 100.0 |
- Sera from 51 vaccinees negative at baseline also for anti-Tat Abs against C, D and A clades were tested between week 12 and week 24 after immunization with the B-clade Tat protein. All patients mounted anti-Tat Ab responses against A, C, and/or D clade